Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Tobramycin PF CMI 07 Oct 2022
Tobramycin Injection CMI 07 Oct 2022
DBL Tobramycin Injection CMI 07 Oct 2022
Gentamicin Injection CMI 07 Oct 2022
Dosulepin Viatris (formerly Dosulepin Mylan) PI 07 Oct 2022

New products

Product name Type Date released
DBL Gentamicin Sulfate CMI 07 Oct 2022
Flopen Viatris CMI 07 Oct 2022
Flopen Viatris PI 07 Oct 2022
Ostelin Vitamin D 7000IU CMI 06 Oct 2022
DBL Gentamicin Sulfate PI 28 Sep 2022